INSIGHT REPORT  #5    

 MAY 22, 1998  

wpeA1.jpg (787 bytes) mdi Consultants’

INSIGHT REPORT


I

N

S

I

G

H

T

wpeA0.jpg (698 bytes)

Design Review is now for real!

Well, it may be hard to believe but it has been a year since the FDA issued the revised GMP (now called the QSR) regulations. Though there had been a small sampling of companies that had the "GOOD FORTUNE" to have been inspected in the past year the real test of these new regulations will now be seen, especially as they will relate to the Design Control.

This should be an interesting exercise. What I have seen in the past year, luckily to being present during FDA inspections of several companies, this design review regulations is going to be like opening a can of worms for the FDA.

It is interesting that the best design review inspections I have witnessed were conducted during Foreign inspections. This would actually make some sense since Foreign inspections are conducted usually by the more experienced FDA investigators who would have a better understanding of the regulations. Also, during the inspection of foreign companies the FDA investigator tends to use a more understanding and training approach to their inspections.

The FDA inspections of domestic firms are going to cause havoc for the companies and complete confusion for the investigators who for the most part and not familiar with these regulations, how they are to be audited and enforced. We will have to wait and see the FDA's compliance policy guide on the inspection of companies using these new regulations.

In the meantime, how does a company prepare for this Design Review inspection? This is an interesting question if you are a small medical device manufacturer and don't have an engineering staff. The best advise I could give at this time, without know how the FDA intends to enforce the Design Control section of the QSR is to attempt to document to the best of your ability all your design operations.

In any case, you will be required to have a Design Control procedure that should address all aspects of the regulations so that the FDA investigator could review it, in the event you did not actually perform any design reviews.

As soon as I obtain a copy of the updated FDA's Compliance Policy for inspecting medical device manufacturers, I will provide you some guidance on how to conduct design control and what the expected consequences would be if you are found not complying with this newly enforced regulation.

If you have experienced a design control inspection by the FDA and want to tell others how it went, please let me know and I will post it on this site.

 

NEXT MONTH - "The CE mark and the US Medical Device Industry"

If you have any comments on these INSIGHTS we hope that you let us hear them. If you have any of your own INSIGHTS that you feel would be of value to other companies, we would be pleased to hear from you and to discuss them with you and if you allow, we would even put them up on this site for others to learn from.
e-mail INSIGHT

Copyright 1998 mdi Consultants, Inc.

Close this window